InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by BATE KENNETH, Director. Insider active across 3 companies, notably Epizyme, Inc.. Aggregated, 11 disclosures have been logged. History available since 11 June 2021. The latest transaction was filed on 20 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations11 total
715 shares0Common StockSEC:0001628280-25-032863:0
6,000 shares@ US$111.0687.8% of flowCommon StockSEC:0001628280-25-009076:0
714 shares0Common StockSEC:0000950170-24-078754:0
10,000 shares@ US$9.4512.2% of flowCommon StockSEC:0000899243-24-000245:0
1,198 shares0Common StockSEC:0000899243-23-016056:0
375 shares@ US$15.00100.0% of flowCommon StockSEC:0000899243-23-002195:0
8,060 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028858:0
8,994 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028858:1
8,994 shares0Common Stock, par value $0.0001SEC:0000899243-22-018843:0
8,060 shares0Common Stock, par value $0.0001SEC:0000899243-21-023878
8,060 shares0Common Stock, par value $0.0001SEC:0000899243-21-023878:0
11 of 11 declarations
About BATE KENNETH
Kenneth Bate is a Board Member at Epizyme, Inc. He contributes to the governance of the company by participating in strategy formulation and critical decision-making. His experience in the industry is an asset to the board.
